Form 4: Biodesix CEO Scott Hutton Converts Preferred Stock to Common Stock
SEC Form 4 Filing
Biodesix CEO Scott Hutton converted Series A Non-Voting Convertible Preferred Stock into common stock following stockholder approval at the company's annual meeting.
Summary
- On May 23, 2024, Biodesix CEO Scott Hutton converted 653 shares of Series A Non-Voting Convertible Preferred Stock into 26,120 shares of Common Stock.
- This conversion occurred after the Issuer's stockholders approved the conversion at the annual meeting held on May 21, 2024.
- Each share of Preferred Stock automatically converted into 40 shares of Common Stock.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing related to a stock conversion, which is neither particularly positive nor negative. It reflects standard corporate governance procedures.
Industry Context
Stock conversions are a common corporate action, often undertaken to simplify the capital structure or to provide executives with more direct ownership in the company's equity.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock at its 2024 annual meeting of stockholders. |
| 05/23/2024 | Conversion of Series A Non-Voting Convertible Preferred Stock into Common Stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.